Ian Read leaves the pharmaceutical company, with eight years of deal-making tarnished by two failed takeovers aimed at moving earnings overseas.
from NYT > Business Day https://ift.tt/2QpUi9m
Subscribe to:
Post Comments (Atom)
One chart helps explain why Elon Musk is axing Tesla's Model S and X
Tesla is giving the Model X the ax. Its sales have likely been in decline for a few years. Wang Gang/VCG via Getty Images Elon Musk sai...
-
Caroline Purser/Getty Images The S&P 500 has shed 4% since the beginning of the year as Big Tech stocks decline. However, previou...
-
AP Photo The Magnificent Seven stocks' dominance may soon fade, warns Glenmede Investment Management. Current market concentratio...
-
The Bell V-280 Valor was selected as the Army's future long-range assault aircraft in 2022. Photo courtesy of Bell The US Army desi...
No comments:
Post a Comment